Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioma 1 Communication Disorders 1

Interventions

pembrolizumab 302 Carboplatin 155 Nivolumab 154 Cisplatin 139 Cyclophosphamide 130 Paclitaxel 127 Magnetic Resonance Spectroscopy 98 Specimen Handling 95 Radiotherapy 90 Gemcitabine 87 Dexamethasone 83 Biopsy 81 Ipilimumab 78 Docetaxel 75 Doxorubicin 75 Rituximab 69 Etoposide 67 atezolizumab 61 durvalumab 60 Lenalidomide 59 Radiation 59 Pemetrexed 58 Taxes 57 Bevacizumab 54 Prednisone 54 fludarabine 54 olaparib 53 Cytarabine 49 Vincristine 49 Fluorouracil 48

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Speech Therapy × 1 year × Clear all

NCT05189366 2026-04-14

SOPHNEURO

Institut Cancerologie de l'Ouest

Phase NA Terminated

13 enrolled 8 charts

Communication Disorders, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡